Cardiogenic and obstructive shock

This article doesn't meet WikiLectures quality standards.

This article seems to not fulfill most of the items on our Editorial Process checklist. As such, it's going to be deleted soon. To the author of this article: if you still work on this article, make sure to replace this template with the Under construction template. However, be aware that if you don't make any changes to the article after that soon enough, the article will still be deleted. To find out what you need to do to improve this article, read Help:Editorial process. Feel free to ask for help on Forum:Support. To see how articles on WikiLectures should look like, check out articles in Category:Finished articles. For more information, contact the user who inserted this template, you can find them in the Page History (under the "Actions" button). Last user who modified this page: ShadyMedic

Cardiogenic and Obstructive Shock

Introduction

Cardiogenic and obstructive shock are forms of circulatory shock characterized by critical impairment of effective cardiac output and subsequent failure of tissue perfusion. Although both present with hypotension and signs of organ hypoxia, the underlying mechanisms differ substantially. Cardiogenic shock arises from intrinsic pump failure of the heart, meaning that even with adequate blood volume, the heart cannot generate sufficient stroke volume. Obstructive shock, however, occurs when an external mechanical barrier prevents normal cardiac filling or forward flow. Recognizing these distinctions is essential because the therapeutic approach depends heavily on the underlying cause, and delayed treatment carries a high mortality risk.

Cardiogenic Shock

Cardiogenic shock develops when the heart’s pumping ability becomes severely compromised, leading to a profound reduction in cardiac output. The most common cause is acute myocardial infarction, particularly when a large portion of the left ventricle is affected. Myocardial ischemia impairs contractility, producing a dramatic fall in stroke volume and systemic perfusion. Mechanical complications of myocardial infarction, such as papillary muscle rupture leading to acute mitral regurgitation, ventricular septal rupture, or free wall rupture causing cardiac tamponade, may also precipitate cardiogenic shock. Arrhythmias—including sustained ventricular tachycardia, ventricular fibrillation, or severe bradyarrhythmias—can acutely reduce cardiac output. Valvular disorders such as critical aortic stenosis or acute aortic or mitral regurgitation are additional contributors.

The underlying pathophysiology is characterized by a downward spiral of reduced cardiac output, increased sympathetic activation, and elevated systemic vascular resistance. While vasoconstriction initially attempts to maintain perfusion, the increased afterload further impairs left ventricular ejection. Meanwhile, rising left-sided pressures lead to pulmonary congestion and hypoxia, worsening myocardial oxygen supply and contributing to organ dysfunction. Clinically, patients show hypotension, tachycardia, cool and clammy skin due to vasoconstriction, elevated jugular venous pressure, pulmonary crackles, oliguria, and mental status changes. Laboratory evaluation reveals elevated cardiac biomarkers such as troponin, metabolic acidosis, and high lactate. Echocardiography is essential for identifying systolic dysfunction, wall-motion abnormalities, or structural complications.

Management focuses on restoring coronary perfusion and supporting the failing myocardium. In acute myocardial infarction, urgent percutaneous coronary intervention or thrombolysis improves survival. Hemodynamic stabilization requires cautious fluid management, vasopressors such as norepinephrine to maintain perfusion, and inotropes such as dobutamine to enhance contractility. In refractory cases, mechanical circulatory support devices—such as the intra-aortic balloon pump, Impella pump, or venoarterial ECMO—may be necessary. Treatment of arrhythmias or emergency repair of mechanical complications is equally important.

Obstructive Shock

Obstructive shock occurs when a physical impediment prevents normal cardiac filling or ejection. Despite intrinsic myocardial function being intact, the obstruction results in decreased stroke volume and cardiac output. The most common causes include massive pulmonary embolism, cardiac tamponade, and tension pneumothorax.

A massive pulmonary embolism obstructs the pulmonary arterial circulation, leading to a sudden rise in right ventricular afterload. The right ventricle becomes acutely dilated and unable to pump effectively, decreasing left ventricular preload and systemic perfusion. Patients typically present with sudden dyspnea, chest pain, hypotension, tachycardia, and elevated jugular venous pressure. Echocardiography may show right ventricular dilation and dysfunction.

In cardiac tamponade, fluid accumulates rapidly within the pericardial sac. Because the pericardium is relatively inelastic, increased intrapericardial pressure compresses the cardiac chambers and restricts diastolic filling. This equalization of diastolic pressures leads to reduced stroke volume and hypotension. The classic Beck’s triad—hypotension, muffled heart sounds, and jugular venous distention—may be present. Pulsus paradoxus, the fall in systolic pressure during inspiration, is another characteristic finding. Diagnosis relies on echocardiography demonstrating pericardial effusion with chamber collapse.

A tension pneumothorax arises when air accumulates under pressure within the pleural cavity, collapsing the lung and shifting the mediastinum. Venous return to the heart is compromised, leading to hypotension and obstructive shock. Tracheal deviation, absent breath sounds on the affected side, and distended neck veins are suggestive signs.

Management of obstructive shock requires immediate removal of the obstruction. Pulmonary embolism is treated with anticoagulation, systemic thrombolysis, or surgical/catheter embolectomy in unstable cases. Cardiac tamponade necessitates emergency pericardiocentesis. Tension pneumothorax must be treated with immediate needle decompression followed by chest tube placement. Vasopressors and oxygen supplementation may be needed temporarily but will not resolve shock until the obstruction is relieved.

Summary

Cardiogenic and obstructive shock share the final pathway of inadequate cardiac output and impaired tissue perfusion but differ significantly in their pathogenesis. Cardiogenic shock results from intrinsic myocardial pump failure and is commonly associated with myocardial infarction and severe systolic dysfunction. Obstructive shock arises from impediments to ventricular filling or forward flow, as seen in pulmonary embolism, cardiac tamponade, and tension pneumothorax. Clinical distinction is vital because while cardiogenic shock requires inotropes, revascularization, and support of cardiac function, obstructive shock requires urgent relief of the underlying mechanical obstruction. Recognizing key features of each type enables rapid intervention and improves survival.

Sources

1. Kumar V., Abbas A.K., Aster J.C.

Robbins and Cotran Pathologic Basis of Disease, 10th edition.

Elsevier, Philadelphia, 2021.

2. Hall J.E., Guyton A.C.

Guyton and Hall Textbook of Medical Physiology, 14th edition.

Elsevier, Philadelphia, 2021.

3. McCance K.L., Huether S.E.

Pathophysiology: The Biologic Basis for Disease in Adults and Children, 8th edition.

Elsevier, St. Louis, 2019.

4. AMBOSS Medical Knowledge Platform.

Articles: “Cardiogenic Shock,” “Obstructive Shock.” Accessed 2024.

5. UpToDate, Wolters Kluwer.

“Evaluation and Management of Cardiogenic Shock,” “Causes of Obstructive Shock.” Accessed 2024.